Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer
Clinical trial NCT00016224 · COMPLETED
Trial details
- NCT number
- NCT00016224
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2004-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.